Impact of pharmaceutical and non-pharmaceutical interventions on COVID-19 in Tunisia
In terms of lowering the risk of transmission and mortality, the NP strategy at the beginning of the epidemic outperformed the IP strategy during the outbreak.
Authors
- Amel Gara
- Inès Bouanène (ORCID: https://orcid.org/0000-0002-8403-5053)
- Manel Ben Fredj (ORCID: https://orcid.org/0000-0001-8529-2660)
- Meriem Kacem (ORCID: https://orcid.org/0000-0003-4153-9902)
- Héla Abroug (ORCID: https://orcid.org/0000-0002-9666-4914)
- M. Ben Belgacem (ORCID: https://orcid.org/0009-0002-0855-4959)
- Cyrine Bennasrallah
- Asma Sriha Belguith (ORCID: https://orcid.org/0000-0001-5167-5102)
- Syrine Gallas
- Wafa Dhouib (ORCID: https://orcid.org/0000-0001-8886-9824)
- Donia Ben Hassine (ORCID: https://orcid.org/0000-0003-1886-159X)
- Amani Maatouk (ORCID: https://orcid.org/0000-0001-7041-0249)
- Imen Zemni (ORCID: https://orcid.org/0000-0002-3273-7811)
Institutions
- University of Monastir (TN)
- Hospital Fatuma Bourguiba Monastir (TN)
Publication Details
- Journal
- BMC Public Health
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1186/s12889-024-19236-9
- Citations
- 4
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.56